cervical pre-cancer
Capitalizing on the success of mRNA-based vaccines for COVID-19, Nutcracker is developing mRNA-based therapeutics with immunostimulatory properties.
Qiagen, Inovio Expand CDx Partnership, Starting With NGS Test for Cervical Dysplasia Therapy
The partners will develop a test to identify women most likely to benefit from VGX-3100, Inovio's immunotherapy to treat HPV-associated advanced cervical dysplasia.
FDA Approves Expanded Use for Roche Cytology Test in Patients With Cervical Cancer
The test detects the presence of two biomarkers within a single cell associated with HPV infections that can progress to cervical cancer.
Qiagen, Inovio to Develop CDx for Immunotherapy Targeting Precancerous Cervical Lesions
The test will guide clinical decision making related to Inovio's DNA-based immunotherapy to treat cervical dysplasia caused by human papillomavirus.